Home > Analyses > Financial Services > MetLife, Inc.
MetLife, Inc. safeguards millions of lives globally through its diverse insurance and financial products. Its leadership in life insurance, annuities, and employee benefits reflects decades of innovation and trusted service. MetLife’s expansive footprint spans five continents, combining scale with tailored solutions. As the insurance landscape evolves, I question whether MetLife’s solid fundamentals and strategic positioning continue to justify its valuation and promise sustainable growth ahead.
Table of contents
Business Model & Company Overview
MetLife, Inc., founded in 1863 and headquartered in New York City, stands as a titan in life insurance and financial services. Its core business spans a comprehensive ecosystem of life, dental, disability, and annuity products, creating a seamless risk management and wealth protection platform. MetLife’s global footprint includes five major segments covering the U.S., Asia, Latin America, Europe, the Middle East, and Africa, reflecting a diversified and resilient operational structure.
The company’s revenue engine balances traditional insurance premiums with growing annuities and employee benefits services. MetLife leverages a mix of fixed, indexed-linked, and variable annuities alongside pension risk transfers and capital markets products to generate steady, recurring income. This strategic presence across Americas, Europe, and Asia bolsters its competitive advantage by diversifying risk and capturing growth in emerging markets. MetLife’s economic moat lies in its scale, trusted brand, and ability to innovate within a complex regulatory landscape.
Financial Performance & Fundamental Metrics
I analyze MetLife, Inc.’s income statement, key financial ratios, and dividend payout policy to reveal its underlying profitability and shareholder value potential.
Income Statement
Below is MetLife, Inc.’s income statement summary for the fiscal years 2021 through 2025, reported in USD.
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue | 63.4B | 67.9B | 67.7B | 69.9B | 77.1B |
| Cost of Revenue | 46.5B | 49.0B | 50.4B | 50.9B | 49.1B |
| Operating Expenses | 8.3B | 12.6B | 15.1B | 13.4B | 23.4B |
| Gross Profit | 16.8B | 18.9B | 17.3B | 19.0B | 28.0B |
| EBITDA | 10.1B | 8.0B | 3.9B | 7.4B | 5.7B |
| EBIT | 9.4B | 7.3B | 3.2B | 6.7B | 5.7B |
| Interest Expense | 920M | 938M | 1.0B | 1.0B | 1.1B |
| Net Income | 6.9B | 5.3B | 1.6B | 4.4B | 3.4B |
| EPS | 7.7 | 6.3 | 1.8 | 6.0 | 4.8 |
| Filing Date | 2022-02-18 | 2023-02-23 | 2024-02-16 | 2025-02-21 | 2026-02-19 |
Income Statement Evolution
MetLife’s revenue grew 21.65% from 2021 to 2025, with a 10.2% increase in the last year alone. However, net income declined sharply by 50.7% over the period. Gross margin improved favorably to 36.4%, while EBIT and net margins showed neutral to unfavorable trends, reflecting margin pressure despite top-line growth.
Is the Income Statement Favorable?
In 2025, revenue rose to $77.1B, a favorable 10.2% increase, but net income dropped 30.7% to $3.38B. EBIT margin held steady at 7.4%, while net margin fell to 4.4%. Operating expenses grew in line with revenue, but declines in EBIT and net income indicate weakening profitability fundamentals overall.
Financial Ratios
The following table summarizes key financial ratios for MetLife, Inc. from 2021 through 2025, providing insight into profitability, valuation, liquidity, leverage, and efficiency:
| Ratios | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Margin | 11% | 8% | 2% | 6% | 4% |
| ROE | 10% | 18% | 5% | 16% | 12% |
| ROIC | 29% | 1% | 0% | 6% | 4% |
| P/E | 7.5 | 11 | 32 | 13 | 16 |
| P/B | 0.76 | 1.89 | 1.68 | 2.06 | 1.85 |
| Current Ratio | 1.7 | 0 | 2783 | 0 | 0 |
| Quick Ratio | 1.7 | 0 | 2783 | 0 | 0 |
| D/E | 0.26 | 0.60 | 0.63 | 0.68 | 0.68 |
| Debt-to-Assets | 2.3% | 2.7% | 2.7% | 2.8% | 2.6% |
| Interest Coverage | 9.3 | 6.8 | 2.1 | 5.4 | 4.4 |
| Asset Turnover | 0.08 | 0.10 | 0.10 | 0.10 | 0.10 |
| Fixed Asset Turnover | 0 | 20 | 19 | 38 | 0 |
| Dividend Yield | 3.6% | 3.2% | 3.5% | 3.1% | 2.8% |
Evolution of Financial Ratios
MetLife’s Return on Equity (ROE) showed volatility, peaking near 17.7% in 2022 before declining to 11.9% in 2025, indicating slowed profitability. The Current Ratio data is inconsistent, with some years reporting zero, suggesting liquidity concerns. Debt-to-Equity Ratio remained relatively stable around 0.6 to 0.7, reflecting a consistent leverage strategy.
Are the Financial Ratios Favorable?
In 2025, profitability metrics such as net margin (4.38%) and ROIC (4.28%) were unfavorable, lagging behind the 6.36% WACC, signaling weak capital returns. Liquidity ratios like Current and Quick Ratios were unfavorable, posing potential short-term risk. Conversely, low debt-to-assets (2.59%) and strong interest coverage (5.39) were favorable. Overall, the ratios suggest a slightly unfavorable financial position.
Shareholder Return Policy
MetLife, Inc. maintains a consistent dividend payout ratio around 40-44%, with a dividend yield near 2.8%-3.5%. The company supports dividends with ample free cash flow, ensuring coverage above 1.8x, while also engaging in share buybacks.
This disciplined approach balances shareholder returns and capital reinvestment. The stable dividend and buyback program suggest a commitment to sustainable long-term value creation, aligning distribution policies with financial prudence and operational cash flow generation.
Score analysis
Here is the radar chart summarizing MetLife, Inc.’s key financial metric scores:
MetLife scores very favorably on discounted cash flow (5) and favorably on return on equity (4). However, return on assets (2), debt to equity (2), price to earnings (2), and price to book (2) scores are all unfavorable, reflecting weaknesses in operational efficiency, leverage, and valuation metrics.
Analysis of the company’s bankruptcy risk
The Altman Z-Score places MetLife in the distress zone, indicating a high risk of financial distress and potential bankruptcy:
Is the company in good financial health?
The Piotroski Score diagram offers insights into MetLife’s overall financial strength:
With a strong Piotroski Score of 7, MetLife demonstrates solid financial health, reflecting good profitability, leverage, and operational efficiency despite some other metric weaknesses.
Competitive Landscape & Sector Positioning
This section analyzes MetLife, Inc.’s strategic positioning, revenue segments, key products, and main competitors. I will assess whether MetLife holds a competitive advantage over its peers in the insurance and financial services sector.
Strategic Positioning
MetLife, Inc. maintains a diversified global presence with strong revenue streams from the U.S. (50B in 2023), Asia (11B), Latin America (7.4B), and EMEA (2.5B). Its product portfolio spans insurance, annuities, employee benefits, and asset management, reflecting broad sector coverage and geographic reach.
Revenue by Segment
This pie chart illustrates MetLife, Inc.’s revenue breakdown by product segment for fiscal year 2025, highlighting the diversity and scale of its service offerings.
In 2025, prepaid legal plans lead with $637M, followed closely by vision fee-for-service at $561M and other service contracts at $432M. Fee-based investment management services remain significant at $369M, while administrative and distribution services contribute smaller but steady revenue of $295M and $142M respectively. The mix shows a tilt toward specialty service contracts, indicating a strategic shift toward diversified, fee-driven income streams.
Key Products & Brands
MetLife’s revenue streams span diverse insurance and financial services sectors, reflecting broad market coverage:
| Product | Description |
|---|---|
| Group Benefits | Life, dental, group short- and long-term disability, vision, accident, and health coverages for groups. |
| Retirement and Income Solutions | Fixed, indexed-linked, variable annuities, pension products, and income annuities for retirement planning. |
| Asia, Latin America, EMEA Segments | Regional insurance and financial services tailored to local markets across Asia, Latin America, EMEA. |
| MetLife Holdings | General and separate account products, synthetic guaranteed interest contracts, and funding agreements. |
| Administrative Service | Administrative services-only contracts and prepaid legal plans offered to employers. |
| Distribution Service | Services supporting insurance distribution channels. |
| Fee-based Investment Management Services | Asset management services generating fee revenue. |
| Other Revenue from Service Contracts | Miscellaneous service contract revenues from customers. |
| Prepaid Legal Plans and Administrative-only Contracts | Legal plans and administrative service contracts sold to employers. |
| Vision Fee for Service Arrangements | Vision care insurance services provided under fee arrangements. |
MetLife’s portfolio balances traditional insurance with growing fee-based and administrative services. This diversification supports stable revenue amid market cycles.
Main Competitors
There are 4 main competitors in the Financial Services sector; the table lists the top 4 leaders by market capitalization:
| Competitor | Market Cap. |
|---|---|
| Aflac Incorporated | 59.6B |
| MetLife, Inc. | 52.9B |
| Prudential Financial, Inc. | 40.2B |
| Globe Life Inc. | 11.0B |
MetLife ranks 2nd among its 4 main competitors with a market cap at 87.4% of the leader, Aflac. It stands above the average market cap of 41B and the median of 46.6B in its sector. MetLife enjoys a 14.4% premium over its nearest rival, Prudential, underscoring a strong position in the life insurance industry.
Comparisons with competitors
Check out how we compare the company to its competitors:
Does MET have a competitive advantage?
MetLife, Inc. currently does not present a competitive advantage. Its return on invested capital (ROIC) is below its cost of capital, signaling value destruction and declining profitability over 2021-2025.
Looking ahead, MetLife’s broad product range across key regions including the U.S., Asia, and Latin America offers growth opportunities. Expansion in specialized insurance products and emerging markets may support future revenue diversification.
SWOT Analysis
This analysis highlights key internal and external factors shaping MetLife’s strategic position.
Strengths
- strong brand recognition
- diversified global footprint
- stable dividend yield
Weaknesses
- declining ROIC signals value destruction
- unfavorable net margin trend
- weak liquidity ratios
Opportunities
- expanding Asian and Latin American markets
- growing demand for retirement products
- increasing digital insurance platforms
Threats
- intense competition in life insurance
- regulatory changes in multiple regions
- economic downturns affecting investment returns
MetLife faces significant challenges with declining profitability and liquidity issues. However, its global reach and dividend stability offer a base to leverage growth in emerging markets and digital innovation. Strategic focus on operational efficiency and capital allocation is critical to reverse value erosion.
Stock Price Action Analysis
The weekly stock chart for MetLife, Inc. shows price movements over the last 12 months, highlighting key highs and lows:
Trend Analysis
Over the past 12 months, MetLife’s stock price increased by 6.73%, indicating a bullish trend. The stock reached a high of 88.23 and a low of 68.55, with price acceleration slowing down as the trend decelerates. Volatility, measured by a 4.66 standard deviation, remains moderate.
Volume Analysis
In the last three months, trading volume shows a decreasing trend. Seller volumes slightly exceeded buyer volumes, with buyers representing 45.35%. This seller dominance suggests cautious investor sentiment and lower market participation during this period.
Target Prices
Analysts set a clear target consensus for MetLife, Inc., reflecting measured optimism.
| Target Low | Target High | Consensus |
|---|---|---|
| 84 | 101 | 95 |
The target range from 84 to 101 signals moderate upside potential. The consensus at 95 suggests steady confidence in MetLife’s valuation.
Don’t Let Luck Decide Your Entry Point
Optimize your entry points with our advanced ProRealTime indicators. You’ll get efficient buy signals with precise price targets for maximum performance. Start outperforming now!
Analyst & Consumer Opinions
This section examines MetLife, Inc.’s recent analyst ratings alongside consumer feedback and sentiment trends in 2026.
Stock Grades
Here are the latest verified stock grades from well-known financial firms for MetLife, Inc.:
| Grading Company | Action | New Grade | Date |
|---|---|---|---|
| Evercore ISI Group | Maintain | In Line | 2026-02-11 |
| UBS | Maintain | Buy | 2026-02-05 |
| Wells Fargo | Maintain | Overweight | 2026-01-13 |
| UBS | Maintain | Buy | 2026-01-08 |
| Wells Fargo | Maintain | Overweight | 2025-12-23 |
| Keefe, Bruyette & Woods | Maintain | Outperform | 2025-11-11 |
| Wells Fargo | Maintain | Overweight | 2025-11-07 |
| UBS | Maintain | Buy | 2025-11-06 |
| B of A Securities | Maintain | Buy | 2025-11-06 |
| B of A Securities | Maintain | Buy | 2025-10-13 |
The consensus strongly favors a “Buy” stance, with all recent actions maintaining positive or neutral ratings. Notably, UBS and B of A Securities consistently rate MetLife as a Buy, reinforcing steady confidence.
Consumer Opinions
MetLife, Inc. enjoys a strong reputation among customers, but some concerns persist.
| Positive Reviews | Negative Reviews |
|---|---|
| Responsive customer service resolves issues quickly. | Claims processing can be slow at times. |
| Comprehensive insurance coverage options. | Premiums have increased noticeably over the last year. |
| User-friendly online platform simplifies management. | Some customers find policy terms complex to understand. |
Overall, consumers praise MetLife’s service responsiveness and robust coverage. However, delays in claims and rising premiums remain consistent pain points. Transparency in policy details could improve customer satisfaction.
Risk Analysis
Below is a summary table highlighting key risks facing MetLife, Inc. as of 2026:
| Category | Description | Probability | Impact |
|---|---|---|---|
| Financial Health | Altman Z-Score in distress zone signals high bankruptcy risk. | High | Severe |
| Profitability | Low net margin (4.38%) and ROIC (4.28%) below WACC (6.36%). | Medium | Moderate |
| Liquidity | Current and quick ratios at zero indicate weak short-term liquidity. | High | High |
| Market Valuation | Neutral P/E (15.53) and P/B (1.85) ratios suggest fair valuation. | Medium | Moderate |
| Leverage | Debt-to-equity ratio neutral but interest coverage favorable. | Low | Low |
| Operational Efficiency | Poor asset turnover ratios highlight inefficiency in asset use. | Medium | Moderate |
MetLife’s most pressing risks are its weak liquidity and alarming Altman Z-Score of 0.38, firmly in the distress zone. This suggests a heightened risk of financial distress despite solid market positioning. Profitability struggles further undermine its ability to generate returns above its cost of capital. Investors must weigh these red flags against its strong Piotroski score and favorable dividend yield.
Should You Buy MetLife, Inc.?
MetLife appears to be experiencing declining operational efficiency and a very unfavorable moat, suggesting value erosion. Despite a manageable leverage profile, its Altman Z-Score signals distress. The overall B rating and strong Piotroski score suggest moderate investment appeal with notable risks.
Strength & Efficiency Pillars
MetLife, Inc. exhibits operational resilience with a solid gross margin of 36.36% and a favorable interest expense ratio of 1.38%. Its return on equity at 11.9% remains neutral but stable. However, the return on invested capital (ROIC) of 4.28% falls below the weighted average cost of capital (WACC) at 6.36%, indicating the company is currently not a value creator. Despite decent operational margins, declining profitability trends highlight challenges in sustaining efficiency.
Weaknesses and Drawbacks
The company is in financial distress, as shown by an Altman Z-Score of 0.38, placing it deep in the Distress Zone and signaling a high bankruptcy risk. This critical solvency concern overshadows other metrics. Additionally, MetLife suffers from unfavorable liquidity ratios, with a current ratio and quick ratio both at zero, signaling potential short-term liquidity problems. Valuation metrics remain neutral, but the seller dominance in recent trading (buyer dominance at only 45.35%) points to short-term market pressure.
Our Final Verdict about MetLife, Inc.
Despite some operational strengths, MetLife’s financial distress reflected in its Altman Z-Score of 0.38 makes the investment profile highly speculative. The solvency risk outweighs profitability and technical signals. Investors might consider the company too risky for conservative capital despite a bullish long-term trend and strong Piotroski score of 7. Caution and close monitoring remain essential before any exposure.
Disclaimer: This content is for informational purposes only and does not constitute financial, investment, or other professional advice. Investing in financial markets involves a significant risk of loss, and past performance is not indicative of future results.
Additional Resources
- MetLife, Inc. $MET Shares Purchased by Tredje AP fonden – MarketBeat (Feb 21, 2026)
- MetLife, Inc. (MET) Announces Dividend Declarations on Preferred Stocks – GuruFocus (Feb 20, 2026)
- MetLife Executive to Speak at Raymond James 47th Annual Institutional Investors Conference – Business Wire (Feb 18, 2026)
- HighTower Advisors LLC Has $12.11 Million Holdings in MetLife, Inc. $MET – MarketBeat (Feb 21, 2026)
- “Job Hugging” Is Undermining Workplace Outcomes: New MetLife Study – Stock Titan (Feb 18, 2026)
For more information about MetLife, Inc., please visit the official website: metlife.com
